Scientists at the University of Queensland in Brisbane, Australia, created a rapid vaccine production platform that can be adapted to make various vaccines. The platform uses a new technology called a “molecular clamp,” which helps stabilize viral surface proteins the vaccines use to prevent infections.
Scientists predict the platform could produce hundreds of thousands of vaccine doses ready for testing in as little as 16 weeks. The technology opens the door for the world to quickly respond to new and unknown pathogens.
Launched in 2017, CEPI is an alliance of public, private, philanthropic and civil organizations that aims to advance vaccine development to prevent future epidemics.
More articles on clinical leadership and infection control:
Infectious disease expert: Public health always suffers with political instability
Prescribed opioids raise patients’ pneumonia risk
Flu hospitalizations exceed 1K in Colorado
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
